Quantcast

Latest Adverse event Stories

2014-08-05 23:02:01

A recent regulatory filing exposes that adverse events occurred in 14% of patients taking Acthar in 2013. Spangenberg Shibley & Liber is interested in speaking with anyone who has taken this potentially dangerous prescription drug. Cleveland Ohio (PRWEB) August 05, 2014 Spangenberg Shibley & Liber is interested in speaking with anyone who has taken Acthar, a potentially dangerous prescription drug, and suffered adverse side effects. A recent regulatory filing by Questcor, the...

2014-07-11 23:01:56

A recent regulatory filing exposes that the number of adverse events in 2013 reported by patients taking Acthar was almost 14% of prescriptions. Zoll, Kranz & Borgess is investigating this potentially dangerous drug. Toledo, Ohio (PRWEB) July 11, 2014 As reported by the New York Times (Morgenson 7/10/14) and FiercePharma (Weintraub 7/11/14), a significant number of severe adverse events such as renal failure, increases in blood sugar, abdominal issues and even death from the...

2014-07-09 23:04:27

Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, notes that Xarelto® is surpassing Pradaxa® in the number of reported adverse events, according to the Institute for Safe Medication Practices’ most recent Quarter Watch Report. The attorneys at Schlichter, Bogard & Denton, LLP are offering free and confidential case reviews to those who allege to have suffered serious bleeding events after using Xarelto®. St. Louis, MO (PRWEB) July 09, 2014 According to...

2014-07-03 16:23:13

GREENSBORO, N.C., July 3, 2014 /PRNewswire/ -- ConvaTec has announced that the U.S. Food and Drug Administration (FDA) has classified the company's recently initiated voluntary global recall of Flexi-Seal(TM) CONTROL Fecal Management System (FMS) as a Class I recall. The FDA defines a Class I recall as a situation in which there is a reasonable probability that use of, or exposure to, a violative product will cause serious adverse health consequences or death. ConvaTec began notifying...

2014-06-04 16:26:01

FDA Removes Clinical Hold on Phase 2 Trial (Study 202) SAN DIEGO, June 4, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on patient enrollment and dosing of PEGPH20 in the ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer permitting the study to resume under a revised protocol. Patient enrollment is anticipated to recommence upon review...

2014-05-12 23:07:22

Important webinar to examine the first regulatory year of EU regulations regarding cosmetovigilance. The live broadcast takes place on Thursday, June 5, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) May 12, 2014 The first anniversary is approaching for European regulations for mandatory reporting of serious adverse events temporally related to cosmetic use. Reporting of these events is often complicated by a product’s status as drug in one region, but a cosmetic in...

2014-04-28 23:08:17

Live webinar will focus on the importance of consistent quality practices for management of veterinary pharmacovigilance, particularly, adverse event data. The broadcast takes place on Thursday, May 15, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) April 28, 2014 Many times, the impact of data management during the workflow is underestimated, leading to added resources for remediation. Given that the quality and integrity of veterinary pharmacovigilance data can be...

2014-04-07 23:25:41

MarketReportsOnline.com adds "Chinese guidebook for Adverse Drug Reaction Reporting and Monitoring Regulations (2014)" report to its research store. Dallas, Texas (PRWEB) April 07, 2014 China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with a sustained economic and population growth, Chinese healthcare market has maintained an annual average growth rate above 16% since...

2014-04-01 14:31:40

OHSU analysis in Annals of Internal Medicine finds journals reported adverse events less frequently Medical researchers often presented the findings of their clinical trials in a different way on a federal government website than they did in the medical journals where their studies were ultimately published, according to an Oregon Health & Science University analysis published April 1 in the Annals of Internal Medicine. Researchers' reports in peer-reviewed medical journals often...

2014-03-24 12:30:14

MUMBAI, March 24, 2014 /PRNewswire/ -- Bharat Book Bureau presents Chinese guidebook for Adverse Drug Reaction Reporting and Monitoring Regulations. China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related